StockWatch
·

Aspira Pathlab & Diagnostics Ltd

BSE: 540788

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-3.011.175.369.54Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
-38.27-13.6610.9635.57Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue6.52+27.4%5.12-36.7%8.09+54.2%5.25-9.2%5.78+6.8%5.41-12.5%6.18
Other Income0.14+7.5%0.13-7.2%0.14+29.5%0.11-17.4%0.13+46.5%0.09+17.1%0.08
Total Income6.66+26.9%5.25-36.2%8.23+53.7%5.36-9.3%5.91+7.5%5.50-12.1%6.25
EXPENSES
Expenditure7.35+7.9%6.81+6.4%6.40+30.9%4.89-5.7%5.18+1.3%5.12-2.7%5.26
Tax0.000.000.000.000.00
PROFIT
PBT-0.69+55.9%-1.56-185.1%1.84+291.0%0.47-35.1%0.72+91.9%0.38-61.9%0.99
Net Profit-0.69+55.9%-1.56-185.1%1.84+291.0%0.47-35.1%0.72+91.9%0.38-61.9%0.99
KEY METRICS
OPM %-5.11%+18.53pp-23.64%-50.69pp27.05%+11.41pp15.64%-2.60pp18.24%+21.79pp-3.55%-11.17pp7.62%
NPM %-10.34%+19.41pp-29.75%-52.05pp22.30%+13.54pp8.76%-3.48pp12.24%+5.38pp6.86%-8.97pp15.83%
EPS0.67-55.9%1.52-14.6%1.78+287.0%0.46-34.3%0.70+89.2%0.37-61.5%0.96

Corporate Events

Board MeetingASPIRA
2026
23May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing
Board MeetingASPIRA
2026
10Feb

Board Meeting

consider and approve Unaudited Standalone Financial Results,…

BSE Filing
Board MeetingASPIRA
2025
16May

Board Meeting

Consider and approve Audited Standalone Financial Results al…

BSE Filing
Board MeetingASPIRA
2025
7Feb

Board Meeting

Consider and approve Unaudited Standalone Financial Results …

BSE Filing
Board MeetingASPIRA
2024
12Nov

Board Meeting

Consider and approve Unaudited Standalone and Consolidated F…

BSE Filing
Board MeetingASPIRA
2024
28May

Board Meeting

consider and approve Audited Financial Results (Standalone) …

BSE Filing